Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial

BACKGROUND: Since lifestyle changes are main therapies for non-alcoholic fatty liver disease (NAFLD), changing dietary components (nutritional or bioactive) may play a parallel important role. Few studies have assessed the effects of curcumin on NAFLD (mainly antioxidant and anti-inflammatory effect...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nutr Metab (Lond)
Main Authors: Jazayeri-Tehrani, Seyed Ali, Rezayat, Seyed Mahdi, Mansouri, Siavash, Qorbani, Mostafa, Alavian, Seyed Moayed, Daneshi-Maskooni, Milad, Hosseinzadeh-Attar, Mohammad-Javad
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6348610/
https://ncbi.nlm.nih.gov/pubmed/30705687
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12986-019-0331-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados